Hsbc Holdings PLC Marker Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.37 - $1.0 $6,175 - $16,691	-16,691 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$0.95 - $1.72 $981 - $1,776	-1,033 Reduced 5.83%	16,691 $15,000
Q3 2021 Nov 12, 2021	SELL	$1.68 - $2.88 $1,426 - $2,445	-849 Reduced 4.57%	17,724 $30,000
Q2 2021 Aug 13, 2021	BUY	$1.88 - $3.56 $43 - $81	23 Added 0.12%	18,573 $51,000
Q1 2021 May 14, 2021	SELL	$1.47 - $3.29 $5,860 - $13,117	-3,987 Reduced 17.69%	18,550 $41,000
Q4 2020 Feb 12, 2021	BUY	$1.36 - $1.75 $1,062 - $1,366	781 Added 3.59%	22,537 $32,000
Q2 2020 Aug 14, 2020	BUY	$1.69 - $2.79 $36,767 - $60,699	21,756 New	21,756 $45,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $323M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.